NRGSX
Price
$62.80
Change
+$0.25 (+0.40%)
Updated
Oct 17 closing price
Net Assets
8.71B
NWKCX
Price
$80.16
Change
+$0.20 (+0.25%)
Updated
Oct 17 closing price
Net Assets
1.55B
Interact to see
Advertisement

NRGSX vs NWKCX

Header iconNRGSX vs NWKCX Comparison
Open Charts NRGSX vs NWKCXBanner chart's image
Neuberger Berman Genesis R6
Price$62.80
Change+$0.25 (+0.40%)
VolumeN/A
Net Assets8.71B
Nationwide Geneva Small Cap Gr R6
Price$80.16
Change+$0.20 (+0.25%)
VolumeN/A
Net Assets1.55B
NRGSX vs NWKCX Comparison Chart in %
View a ticker or compare two or three
VS
NRGSX vs. NWKCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRGSX is a Hold and NWKCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.71B vs. NWKCX (1.55B). NRGSX pays higher dividends than NWKCX: NRGSX (0.06) vs NWKCX (0.00). NRGSX was incepted earlier than NWKCX: NRGSX (13 years) vs NWKCX (12 years). NWKCX (0.83) is less costly to investors than NRGSX (0.74). NWKCX is a more actively managed with annual turnover of: 21.28 vs. NRGSX (13.00). NRGSX has a lower initial minimum investment than NWKCX: NRGSX (0) vs NWKCX (1000000). NRGSX annual gain was more profitable for investors over the last year : -10.12 vs. NWKCX (-12.54). NWKCX return over 5 years is better than : 7.40 vs. NRGSX (-2.32).
NRGSXNWKCXNRGSX / NWKCX
Total Expense Ratio0.740.8389%
Annual Report Gross Expense Ratio0.740.8389%
Fund Existence13 years12 years-
Gain YTD-3.902-8.34747%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.71B1.55B562%
Annual Yield % from dividends0.060.00-
Returns for 1 year-10.12-12.5481%
Returns for 3 years5.9019.6230%
Returns for 5 years-2.327.40-31%
Returns for 10 years10.2474.8314%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFNAX73.750.46
+0.63%
Janus Henderson Global Life Sciences A
GGCCX102.840.38
+0.37%
Gabelli Growth C
GMCUX16.770.04
+0.24%
Goldman Sachs Small/Mid Cap Equity R6
RLEFX38.980.04
+0.10%
American Funds American Balanced R5E
MSECX11.320.01
+0.09%
Morgan Stanley Inst International Eq C